NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

Published:2012-06-28 Issue:6 Volume:7 Page:e38783
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ademuyiwa Foluso O.,Bshara Wiam,Attwood Kristopher,Morrison Carl,Edge Stephen B.,Ambrosone Christine B.,O’Connor Tracey L.,Levine Ellis G.,Miliotto Anthony,Ritter Erika,Ritter Gerd,Gnjatic Sacha,Odunsi Kunle

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.;Lancet,2005

2. Triple-negative breast cancer: clinical features and patterns of recurrence.;R Dent;Clin Cancer Res,2007

3. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.;LG Almeida;Nucleic Acids Res,2009

4. Genome-wide analysis of cancer/testis gene expression.;O Hofmann;Proc Natl Acad Sci U S A,2008

5. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.;YT Chen;PLoS One,2011

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study;Virchows Archiv;2024-06-18

2. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials;Journal of Controlled Release;2024-06

3. Prognostic Value of “Basal-like” Morphology, Tumor-Infiltrating Lymphocytes and Multi-MAGE-A Expression in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2024-04-20

4. Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma;Pigment Cell & Melanoma Research;2024-03-20

5. Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade;Scientific Reports;2024-02-09